Ectopic overexpression of transcription factors has been used to reprogram cell fate. For example, virus-mediated overexpression of four transcription factors OCT4, SOX2, MYC, and KLF4, known as Yamanaka factors, can convert somatic cells to induced pluripotent stem (iPS) cells. However, gene-specific switch-on of endogenous gene production without the use of foreign DNA remains a challenge. The small RNA machinery that comprised small RNAs and Argonaute proteins is known to silence gene expression, but can be repurposed to activate gene expression when directed to gene promoters, a phenomenon known as RNA activation or RNAa. By screening of dsRNAs targeting OCT4 promoter, we identified a small activating RNA (saRNA) that activated OCT4 expression in several types of human mesenchymal stem cells (MSCs). We found that saRNA-induced OCT4 activation can be further enhanced by a histone deacetylase inhibitor, valproic acid. Furthermore, introducing OCT4 saRNA in combination with viruses encoding the remaining three Yamanaka factors (SOX2, MYC, and KLF4) into MSCs led to the derivation of partially reprogrammed iPS cells. Findings from this study suggest that, with further optimization, RNAa can be a powerful tool to reprogram cell fate by inducing the expression of endogenous genes.
Get full access to this article
View all access options for this article.
References
1.
TurnerMJ, JiaoAL and SlackFJ. (2014). Autoregulation of lin-4 microRNA transcription by RNA activation (RNAa) in C. elegans. Cell Cycle, 13:772–781.
2.
SethM, ShirayamaM, GuW, IshidateT, ConteDJr., and MelloCC. (2013). The C. elegans CSR-1 argonaute pathway counteracts epigenetic silencing to promote germline gene expression. Dev Cell, 27:656–663.
3.
LiLC, OkinoST, ZhaoH, PookotD, PlaceRF, UrakamiS, EnokidaH and DahiyaR. (2006). Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A, 103:17337–17342.
4.
JanowskiBA, YoungerST, HardyDB, RamR, HuffmanKE and CoreyDR. (2007). Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat Chem Biol, 3:166–173.
5.
HuangV, QinY, WangJ, WangX, PlaceRF, LinG, LueTF and LiLC. (2010). RNAa is conserved in mammalian cells. PLoS One, 5:e8848
6.
HuangV, PlaceRF, PortnoyV, WangJ, QiZ, JiaZ, YuA, ShumanM, YuJ and LiLC. (2012). Upregulation of cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res, 40:1695–1707.
7.
PlaceRF, LiLC, PookotD, NoonanEJ and DahiyaR. (2008). MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A, 105:1608–1613.
8.
DharapA, PokrzywaC, MuraliS, PandiG and VemugantiR. (2013). MicroRNA miR-324-3p induces promoter-mediated expression of RelA gene. PLoS One, 8:e79467
9.
PlaceRF, WangJ, NoonanEJ, MeyersR, ManoharanM, CharisseK, DuncanR, HuangV, WangX and LiLC. (2012). Formulation of small activating RNA into lipidoid nanoparticles inhibits xenograft prostate tumor growth by inducing p21 expression. Mol Ther Nucleic Acids, 1:e15
10.
RenS, KangMR, WangJ, HuangV, PlaceRF, SunY and LiLC. (2013). Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth. Prostate, 73:1591–1601.
11.
TakahashiK and YamanakaS. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126:663–676.
12.
TakahashiK, TanabeK, OhnukiM, NaritaM, IchisakaT, TomodaK and YamanakaS. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–872.
13.
HouP, LiY, ZhangX, LiuC, GuanJ, LiH, ZhaoT, YeJ, YangW, et al. (2013). Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science, 341:651–654.
14.
WarrenL, ManosPD, AhfeldtT, LohYH, LiH, LauF, EbinaW, MandalPK, SmithZD, et al. (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7:618–630.
15.
MiyoshiN, IshiiH, NaganoH, HaraguchiN, DewiDL, KanoY, NishikawaS, TanemuraM, MimoriK, et al. (2011). Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell, 8:633–638.
16.
ZhouH, WuS, JooJY, ZhuS, HanDW, LinT, TraugerS, BienG, YaoS, et al. (2009). Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 4:381–384.
17.
WangX, WangJ, HuangV, PlaceRF and LiLC. (2012). Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation. Biochem J, 443:821–828.
TsaiSY, BouwmanBA, AngYS, KimSJ, LeeDF, LemischkaIR and RendlM. (2011). Single transcription factor reprogramming of hair follicle dermal papilla cells to induced pluripotent stem cells. Stem Cells, 29:964–971.
20.
PardoM, LangB, YuL, ProsserH, BradleyA, BabuMM and ChoudharyJ. (2010). An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. Cell Stem Cell, 6:382–395.
21.
WangX and DaiJ. (2010). Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology. Stem Cells, 28:885–893.
22.
HawkinsPG and MorrisKV. (2010). Transcriptional regulation of Oct4 by a long non-coding RNA antisense to Oct4-pseudogene 5. Transcription, 1:165–175.
23.
LiW, TianE, ChenZX, SunG, YeP, YangS, LuD, XieJ, HoTV, et al. (2012). Identification of Oct4-activating compounds that enhance reprogramming efficiency. Proc Natl Acad Sci U S A, 109:20853–20858.
24.
NingH, LiuG, LinG, GarciaM, LiLC, LueTF and LinCS. (2009). Identification of an aberrant cell line among human adipose tissue-derived stem cell isolates. Differentiation, 77:172–180.
25.
YeL, ChangJC, LinC, SunX, YuJ and KanYW. (2009). Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci U S A, 106:9826–9830.
26.
LiedtkeS, EnczmannJ, WaclawczykS, WernetP and KoglerG. (2007). Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell, 1:364–366.
27.
SunN, PanettaNJ, GuptaDM, WilsonKD, LeeA, JiaF, HuS, CherryAM, RobbinsRC, LongakerMT and WuJC. (2009). Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci U S A, 106:15720–15725.
28.
PortnoyV, HuangV, PlaceRF and LiLC. (2011). Small RNA and transcriptional upregulation. Wiley Interdiscip Rev RNA, 2:748–760.
29.
HuangfuD, OsafuneK, MaehrR, GuoW, EijkelenboomA, ChenS, MuhlesteinW and MeltonDA. (2008). Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol, 26:1269–1275.
30.
ZhuS, LiW, ZhouH, WeiW, AmbasudhanR, LinT, KimJ, ZhangK and DingS. (2010). Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell, 7:651–655.
31.
LiLC. (2014). Chromatin remodeling by the small RNA machinery in mammalian cells. Epigenetics, 9:45–52.
32.
SchwartzJC, YoungerST, NguyenNB, HardyDB, MoniaBP, CoreyDR and JanowskiBA. (2008). Antisense transcripts are targets for activating small RNAs. Nat Struct Mol Biol, 15:842–848.
33.
VoutilaJ, SaetromP, MintzP, SunG, AlluinJ, RossiJJ, HabibNA and KasaharaN. (2012). Gene expression profile changes after short-activating RNA-mediated induction of endogenous pluripotency factors in human mesenchymal stem cells. Mol Ther Nucleic Acids, 1:e35
34.
MartiM, MuleroL, PardoC, MoreraC, CarrioM, Laricchia-RobbioL, EstebanCR and Izpisua BelmonteJC. (2013). Characterization of pluripotent stem cells. Nat Protoc, 8:223–253.
35.
YuJ, ChauKF, VodyanikMA, JiangJ and JiangY. (2011). Efficient feeder-free episomal reprogramming with small molecules. PLoS One, 6:e17557
36.
WangH, CaoN, SpencerCI, NieB, MaT, XuT, ZhangY, WangX, SrivastavaD and DingS. (2014). Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4. Cell Rep, 6:951–960.
37.
SzaboE, RampalliS, RisuenoRM, SchnerchA, MitchellR, Fiebig-ComynA, Levadoux-MartinM and BhatiaM. (2010). Direct conversion of human fibroblasts to multilineage blood progenitors. Nature, 468:521–526.
38.
ZhuS, AmbasudhanR, SunW, KimHJ, TalantovaM, WangX, ZhangM, ZhangY, LaurentT, et al. (2014). Small molecules enable OCT4-mediated direct reprogramming into expandable human neural stem cells. Cell Res, 24:126–129.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
